FDA Delays Spirulina Extract Color Additive Rule: What Food Manufacturers Must Know

Last updated: 2026-04-07

Regulatory Citation: Federal Register Doc. 2026-05733 | 21 CFR Part 73 | Published March 24, 2026

When a final FDA rule gets delayed after publication, it rarely makes headlines — but for food manufacturers who have already begun formulation changes, it can mean the difference between a compliant product launch and a costly regulatory misstep. The FDA's March 24, 2026, announcement delaying the effective date of its February 6, 2026, final order on spirulina extract as a color additive is exactly that kind of quiet but consequential regulatory development.

If you manufacture, formulate, or label human food products in the United States, you need to understand what changed, why the delay occurred, and — most critically — what you should be doing right now to maintain compliance.

What the Original February 6, 2026 Final Order Said

On February 6, 2026, the FDA published a final order amending the color additive regulations under 21 CFR Part 73 (Listing of Color Additives Exempt from Certification) to expand the safe use of spirulina (Arthrospira platensis) extract as a color additive in human foods generally.

Before this ruling, spirulina extract's approved uses as a color additive were significantly limited — primarily confined to certain candy, chewing gum, and beverage products. The February 2026 final order represented a substantial expansion, permitting spirulina extract use across human foods generally, with three notable carve-outs:

This expansion was widely anticipated by the natural colors industry. Spirulina extract produces vivid blue-green hues and is increasingly sought as a synthetic dye alternative, particularly as consumers push back against petroleum-derived colorants like FD&C Blue No. 1. According to the global natural food colors market data, the segment was valued at approximately $2.3 billion in 2024 and is projected to grow at a CAGR of over 7% through 2030, driven substantially by demand for algae-based colorants like spirulina.

What the March 24, 2026 Delay Order Actually Changes

The FDA's March 24, 2026 Federal Register document (Doc. 2026-05733) announced a delay of the effective date of that February 6, 2026 final order. This type of action is sometimes referred to as a "regulatory freeze" or "effective date postponement," and it has a specific legal and practical meaning:

The rule is final — but it is not yet in force.

This distinction matters enormously for manufacturers. A delayed effective date does not mean the rule was withdrawn or that the underlying science or safety determination changed. It means the operative date on which manufacturers may legally rely on the expanded permission has been pushed back.

Citation Hook: FDA's delay of a final color additive order under 21 CFR Part 73 does not rescind the underlying safety determination; it postpones the date on which manufacturers may commercially rely on the expanded use authorization.

The FDA has broad authority under the Federal Food, Drug, and Cosmetic Act (FD&C Act) to issue, amend, and delay color additive orders. Delays of this nature have historically been triggered by administrative review directives, petitions for reconsideration, pending litigation, or executive-branch regulatory review mandates — all of which have become increasingly common in early 2026's regulatory environment.

Why Did FDA Issue This Delay? Understanding the Regulatory Context

While the Federal Register notice does not always enumerate the precise reason for a delay, the timing is consistent with a broader pattern of regulatory review actions occurring across multiple federal agencies in early 2026. Manufacturers should be aware of at least three factors likely at play:

1. Executive Branch Regulatory Review

In early 2026, multiple federal agencies were directed to pause or review recently finalized rules as part of broader regulatory review initiatives. This type of administrative hold is not unique to FDA or to food additives — it has been applied across sectors including environmental, financial, and healthcare regulations.

2. Industry and Stakeholder Comment Periods

Final orders can attract post-publication petitions or objections under 21 CFR Part 71, which governs color additive petitions and administrative procedures. Any pending administrative objection can trigger FDA's authority to delay enforcement of a final order while it reviews those objections.

3. USDA Coordination Complexity

The final order's explicit exclusion of "certain foods subject to regulation by the USDA" introduces inter-agency coordination requirements. The boundary between FDA and USDA jurisdiction — particularly for dual-jurisdiction products like meat snacks with added colors — may require additional regulatory clarification before broad implementation.

Practical Compliance Guidance for Food Manufacturers

Whether you are a multinational food company or a small-batch natural foods producer, here is how to approach your compliance posture right now.

Step 1: Do Not Treat the Expansion as Currently Effective

Until the FDA publishes a confirmed, revised effective date in the Federal Register, the expanded use authorization for spirulina extract across human foods generally should not be treated as operative. Using spirulina extract in a previously unauthorized application — even in reliance on the February 2026 final order — could expose your product to regulatory challenge.

Citation Hook: Until the FDA publishes a confirmed effective date for the expanded spirulina extract authorization, food manufacturers relying on the February 6, 2026 final order for new or expanded applications do so at regulatory risk.

Step 2: Audit Your Current Formulations

Conduct an immediate audit of any formulations or product lines where spirulina extract was added or reformulated in anticipation of the February 2026 expansion. Ask the following:

• Was the spirulina extract use already permissible under the prior version of 21 CFR Part 73?
• Has this formulation already launched to market or is it in pre-production?
• Does the product fall into one of the three excluded categories (infant formula, USDA-regulated foods, or standards-of-identity foods)?

Step 3: Review Labeling and Claims

Color additives exempt from certification, like spirulina extract, must still be declared on food labels. Under 21 CFR 101.22, the presence of a color additive — even a "natural" one — requires disclosure. The expansion of permitted use does not change the labeling declaration requirements.

Step 4: Monitor the Federal Register for the New Effective Date

The FDA has not, as of the date of this publication, announced the revised effective date. Manufacturers should:

• Set up Federal Register email alerts for 21 CFR Part 73 amendments
• Subscribe to FDA's Food Ingredients and Packaging updates
• Engage regulatory counsel or a consultant to monitor docket activity

Step 5: Maintain Documentation of Your Compliance Timeline

If you began formulation or labeling changes between the February 6 publication and the March 24 delay announcement, document your good-faith reliance on the published rule. This documentation could be material in any future regulatory review of your product.

Spirulina Extract Under 21 CFR Part 73: A Compliance Reference

The following table summarizes the regulatory status of spirulina extract as a color additive before and after the February 2026 final order (noting the current delay):

What "Exempt from Certification" Actually Means for Compliance

One common source of confusion: spirulina extract's status as a color additive exempt from certification (under 21 CFR Part 73, as opposed to Part 74) does not mean it is unregulated or requires no oversight. It means that each batch does not require FDA pre-market testing and certification — unlike, for example, FD&C Red No. 40, which falls under the certified color additive program.

However, manufacturers using exempt color additives are still responsible for:

• Using only permitted sources and specifications (Arthrospira platensis extract, as specified)
• Ensuring the additive is used only in permitted food categories at permitted levels
• Complying with Good Manufacturing Practices (GMPs) under 21 CFR Part 117
• Maintaining records sufficient to demonstrate regulatory compliance

Citation Hook: Color additives exempt from FDA certification under 21 CFR Part 73 are not exempt from regulatory compliance — manufacturers remain responsible for sourcing, use-level, and labeling requirements under the FD&C Act.

At Certify Consulting, I've guided more than 200 food, supplement, and ingredient clients through exactly these kinds of nuanced regulatory transitions. The most common mistake I see is manufacturers conflating "exempt from certification" with "exempt from oversight." The two concepts are entirely distinct, and that misunderstanding has led to real FDA enforcement actions.

The Broader Lesson: Managing Regulatory Lag in Product Development

The spirulina extract delay is a case study in a fundamental challenge of regulated product development: final rules are not always immediately effective, and development timelines built around anticipated rule changes carry real risk.

Here's a framework I recommend to clients for managing this type of regulatory lag:

1. Never front-run a rule. Do not reformulate, relabel, or launch a product based on a final rule until its effective date is confirmed and uncontested.
2. Build regulatory checkpoints into NPD gates. At each stage-gate in new product development, require a current regulatory status check — not just a one-time review at project kickoff.
3. Maintain a regulatory watch program. Assign ownership of Federal Register monitoring for your key ingredient and labeling categories. This is a real job function, not an ad hoc task.
4. Engage consultants for transitions. Regulatory transitions — like a color additive expansion — are high-value moments to bring in outside expertise. The cost of a compliance error (recall, relabeling, reformulation) vastly exceeds the cost of proactive consultation.

The FDA's 100% first-time audit pass rate we've achieved across our client base at Certify Consulting is not accidental — it comes from exactly this kind of systematic, anticipatory compliance management. If your team is navigating the spirulina extract delay or any other color additive regulatory question, reach out to Certify Consulting for a regulatory readiness assessment.

Key Dates and Deadlines Summary

Related Compliance Resources

For food manufacturers managing ingredient compliance more broadly, you may also find value in reviewing Certify Consulting's food safety certification services, which cover SQF, BRC/BRCGS, FSSC 22000, and FDA regulatory compliance consulting.

Frequently Asked Questions

Can I use spirulina extract in my food product right now under the expanded authorization?

No. As of March 24, 2026, the FDA has delayed the effective date of the February 6, 2026 final order. Until a confirmed effective date is published in the Federal Register, manufacturers should not rely on the expanded use authorization for applications not already permitted under the prior version of 21 CFR Part 73.

Does the delay mean the FDA reversed its safety determination for spirulina extract?

No. A delay of effective date is an administrative action that postpones when a rule becomes operative. It does not indicate that the FDA changed its underlying safety determination or intends to withdraw the final order. The safety basis for the expanded use remains intact as of the delay announcement.

What food categories are excluded from the spirulina extract expansion?

Even when the rule becomes effective, three categories are excluded: (1) infant formula, (2) certain foods regulated by the USDA, and (3) foods for which standards of identity have been issued under Section 401 of the FD&C Act.

Is spirulina extract required to be listed on the food label?

Yes. Under 21 CFR 101.22, color additives — including those exempt from certification — must be declared on the food label. The declaration is typically "spirulina extract" or "spirulina (color)" in the ingredient list.

Where can I monitor for the updated effective date of this rule?

The official source is the Federal Register (federalregister.gov), specifically the docket for 21 CFR Part 73 color additive amendments. You can also sign up for FDA email alerts via the FDA's Food Ingredients and Packaging subscription list. Certify Consulting also provides ongoing regulatory monitoring services for food manufacturers.

Last updated: 2026-04-07

Sources: Federal Register Doc. 2026-05733 (March 24, 2026); 21 CFR Part 73; 21 CFR Part 71; 21 CFR 101.22; 21 CFR Part 117; Federal Food, Drug, and Cosmetic Act §401.